Medicines Co. (MDCO) Reports Q2 Loss of $0.63/Share
Tweet
Share
E-mail
Get Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Research and development: 23.54M
Today's EPS Names:
AFIB, USDP, BTTX, More
Financial Fact:
Research and development: 23.54M
Today's EPS Names:
AFIB, USDP, BTTX, More
Join SI Premium – FREE
Medicines Co. (NASDAQ: MDCO) reported Q2 EPS of ($0.63), versus ($0.72) reported last year. Revenue for the quarter came in at $1.67 million, versus $10.86 million reported last year.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Palo Alto Networks (PANW) PT Raised to $400 at TD Cowen
- Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
